Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 8,500 shares at $1.49 ($13K) on 2022-02-08, disclosed to the SEC on 2022-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.47 | 5,250 | $8K | 61.4% |
| 2 | $1.49 | 3,250 | $5K | 38.6% |
| Total | $1.48 avg | 8,500 | $13K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |